Tenet Healthcare (THC) to Release Quarterly Earnings on Tuesday

Tenet Healthcare (NYSE:THC) is expected to be announcing its Q3 2025 results before the market opens on Tuesday, October 28th. Analysts expect the company to announce earnings of $3.35 per share and revenue of $5.2557 billion for the quarter. Investors are encouraged to explore the company’s upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Tuesday, October 28, 2025 at 10:30 AM ET.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Tuesday, July 22nd. The company reported $4.02 earnings per share for the quarter, topping the consensus estimate of $2.84 by $1.18. Tenet Healthcare had a return on equity of 24.69% and a net margin of 7.17%.The company had revenue of $5.27 billion for the quarter, compared to analyst estimates of $5.16 billion. During the same quarter last year, the firm earned $2.31 EPS. Tenet Healthcare’s revenue for the quarter was up 3.2% compared to the same quarter last year. On average, analysts expect Tenet Healthcare to post $12 EPS for the current fiscal year and $13 EPS for the next fiscal year.

Tenet Healthcare Price Performance

Shares of NYSE:THC opened at $201.83 on Tuesday. The business’s 50 day moving average is $189.94 and its 200-day moving average is $167.83. The company has a current ratio of 1.71, a quick ratio of 1.63 and a debt-to-equity ratio of 2.39. The firm has a market capitalization of $17.83 billion, a PE ratio of 12.92, a PEG ratio of 0.86 and a beta of 1.52. Tenet Healthcare has a 1-year low of $109.82 and a 1-year high of $207.14.

Wall Street Analyst Weigh In

Several analysts recently commented on THC shares. Raymond James Financial reaffirmed an “outperform” rating and issued a $200.00 price target (up previously from $185.00) on shares of Tenet Healthcare in a research note on Wednesday, July 23rd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $190.00 price target on shares of Tenet Healthcare in a research note on Tuesday, October 7th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Tenet Healthcare in a research note on Wednesday, October 8th. Wall Street Zen raised Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Saturday, July 26th. Finally, KeyCorp boosted their price target on Tenet Healthcare from $205.00 to $225.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $209.25.

Insiders Place Their Bets

In other Tenet Healthcare news, EVP Lisa Y. Foo sold 8,000 shares of the business’s stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $179.53, for a total value of $1,436,240.00. Following the transaction, the executive vice president owned 20,878 shares of the company’s stock, valued at approximately $3,748,227.34. The trade was a 27.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Christopher S. Lynch sold 3,952 shares of the business’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $176.39, for a total value of $697,093.28. Following the completion of the transaction, the director directly owned 12,358 shares in the company, valued at approximately $2,179,827.62. This represents a 24.23% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 90,722 shares of company stock valued at $17,161,015. 0.81% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Tenet Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in THC. Canada Pension Plan Investment Board bought a new stake in shares of Tenet Healthcare during the second quarter worth $35,000. Geneos Wealth Management Inc. raised its position in shares of Tenet Healthcare by 50.9% during the second quarter. Geneos Wealth Management Inc. now owns 264 shares of the company’s stock worth $46,000 after acquiring an additional 89 shares during the last quarter. Quantbot Technologies LP bought a new stake in shares of Tenet Healthcare during the second quarter worth $65,000. Auxier Asset Management bought a new stake in shares of Tenet Healthcare during the second quarter worth $220,000. Finally, Bayesian Capital Management LP bought a new stake in Tenet Healthcare in the second quarter valued at about $229,000. Institutional investors own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.